Similar articles for PMID: 25274656

Year	Number of Results
1991	1
1997	1
1998	1
1999	1
2002	2
2005	4
2006	3
2008	5
2009	4
2010	11
2011	6
2012	11
2013	6
2014	5
2015	6
2016	10
2017	8
2018	8
2019	6
2020	3
2021	2
2022	2
2023	2
2024	0

1

Diabetes therapy and cancer risk: where do we stand when treating patients?

Ching Sun GE, Kashyap SR, Nasr C. Ching Sun GE, et al. Cleve Clin J Med. 2014 Oct;81(10):620-8. doi: 10.3949/ccjm.81a.13140. Cleve Clin J Med. 2014. PMID: 25274656 Free article. Review.

2

Diabetes mellitus and the risk of cancer.

Pandey A, Forte V, Abdallah M, Alickaj A, Mahmud S, Asad S, McFarlane SI. Pandey A, et al. Minerva Endocrinol. 2011 Sep;36(3):187-209. Minerva Endocrinol. 2011. PMID: 22019750 Review.

3

[The relationship of antidiabetic drugs and cancer risk].

Gu YJ, Jia WP. Gu YJ, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Nov;32(11):1170-3. Zhonghua Liu Xing Bing Xue Za Zhi. 2011. PMID: 22336559 Review. Chinese. No abstract available.

4

Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations.

Johnson JA, Yasui Y. Johnson JA, et al. Diabetologia. 2010 Sep;53(9):1823-6. doi: 10.1007/s00125-010-1780-2. Epub 2010 Jun 4. Diabetologia. 2010. PMID: 20523967 No abstract available.

5

Insulin therapy and cancer risk in diabetes mellitus.

Platts J. Platts J. Clin Med (Lond). 2010 Oct;10(5):509-12. doi: 10.7861/clinmedicine.10-5-509. Clin Med (Lond). 2010. PMID: 21117390 Free PMC article. Review. No abstract available.

6

Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment.

Suh S, Kim KW. Suh S, et al. Diabetes Metab J. 2019 Dec;43(6):733-743. doi: 10.4093/dmj.2019.0177. Diabetes Metab J. 2019. PMID: 31902143 Free PMC article. Review.

7

Where now for insulin glargine--a time for pragmatic medicine?

Thomson GA, Craig R. Thomson GA, et al. Int J Clin Pract. 2009 Oct;63(10):1413-5. doi: 10.1111/j.1742-1241.2009.02170.x. Epub 2009 Aug 18. Int J Clin Pract. 2009. PMID: 19689485 No abstract available.

8

Diabetes medications and cancer: a way out of uncertainty.

Gallo M, Esposito K, Giugliano D. Gallo M, et al. Diabetes Res Clin Pract. 2012 Aug;97(2):175-7. doi: 10.1016/j.diabres.2012.04.007. Epub 2012 May 2. Diabetes Res Clin Pract. 2012. PMID: 22560795 No abstract available.

9

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter].

Grouven U, Hemkens LG, Bender R, Sawicki PT. Grouven U, et al. Diabetologia. 2010 Jan;53(1):209-11. doi: 10.1007/s00125-009-1582-6. Epub 2009 Oct 24. Diabetologia. 2010. PMID: 19855952 No abstract available.

10

Type 2 diabetes mellitus and risk of malignancy: is there a strategy to identify a subphenotype of patients with increased susceptibility to endogenous and exogenous hyperinsulinism?

Müssig K, Staiger H, Kantartzis K, Fritsche A, Kanz L, Häring HU. Müssig K, et al. Diabet Med. 2011 Mar;28(3):276-86. doi: 10.1111/j.1464-5491.2010.03132.x. Diabet Med. 2011. PMID: 21309835 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year